In this week's newsletter, also read about Ameera Shah, executive chairperson of Metropolis Healthcare's views on gender ...

The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial ...

Gaekwad had requested Sebi's exemption under takeover rules to propose ₹275 a share for Religare, offering a 17% premium to ...

The Securities and Exchange Board of India (SEBI) on Friday rejected a request from US-based businessman Danny Gaekwad to ...

SEBI rejects Gaekwad's plea for competing open offer, solidifying Burman Group's acquisition bid for Religare Enterprises.

Sebi rejects Danny Gaekwad's application for competing open offer for Religare Enterprises, citing lack of financial proof.

Sebi rejected Digvijay Gaekwad's competing open offer for Religare Enterprises, citing lack of financial ability and ...

Regulator says application 'frivolous', not backed by financial capabilities; also questions due diligence of investment ...

The Securities and Exchange Board of India (SEBI) has denied an exemption request from Digvijay Laxhamsinh Gaekwad (Danny ...

Sebi has ruled that Gaekwad’s competing bid for Religare was not financially credible and violated regulatory timelines, ...

Capital markets regulator Sebi on Friday dismissed an application filed by Digvijay Laxhamsinh Gaekwad seeking an exemption ...